Regeneron Pharmaceuticals Inc（REGN）价格预测REGNRegeneron Pharmaceuticals Inc

Alphio's REGN stock price prediction model matches the current Regeneron Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $796.02 (-0.04%). The 1-week path is $793.00 (-0.42%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Regeneron Pharmaceuticals Inc is a good buy right now due to its current price of $746.54, which is below the analyst price targets ranging from $737 to $960. The recent expansion of the partnership with Sanofi, which includes a $1 billion upfront payment and potential milestone payments of up to $7 billion, significantly strengthens Regeneron's financial position. Additionally, the company has a strong gross margin of 86.56% in the latest quarter, indicating robust profitability. However, the RSI is at 45.655, suggesting it is nearing oversold territory, which could indicate a potential rebound in price. The main risk is the recent 20-day price change of -4.47%, indicating some volatility in the short term.

Regeneron Pharmaceuticals Inc (REGN) last closed at $796.34, gaining +2.31%. These facts feed the 1-day and 1-week REGN price prediction above.